NCCN临床实践指南：肝胆肿瘤(2015.V2)

2015年3月1日,NCCN发布了肝胆肿瘤临床实践指南第1版;“新版指南”对于肝细胞癌有较多更新,主要在筛查和治疗方面进行了更详细的补充和完善。2015年6月2日,NCCN 肝胆肿瘤临床实践指南2015年第2版发布。附件为全英文原版资料,共114页,1.5M,本文件系国内首发。

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

Hepatobiliary CancersVersion 2.2015 http://www.77cn.com.cn

Continue

Version 2.2015, 02/06/15© National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.

http://www.77cn.com.cn

2015年3月1日,NCCN发布了肝胆肿瘤临床实践指南第1版;“新版指南”对于肝细胞癌有较多更新,主要在筛查和治疗方面进行了更详细的补充和完善。2015年6月2日,NCCN 肝胆肿瘤临床实践指南2015年第2版发布。附件为全英文原版资料,共114页,1.5M,本文件系国内首发。

Printed by Maria Chen on 2/10/2015 1:25:04 AM. For personal use only. Not approved for distribution. Copyright© 2015 National Comprehensive Cancer Network, Inc., All Rights Reserved.

NCCN Guidelines Version 2.2015 Panel Members Hepatobiliary Cancers*Al B. Benson, III, MD/Chair Robert H. Lurie Comprehensive Cancer Center of Northwestern University *Michael I. D’Angelica, MD/Vice-Chair¶ Memorial Sloan Kettering Cancer Center Thomas A. Abrams, MD Dana-Farber/Brigham and Women’s Cancer Center Steven R. Alberts, MD, MPH Mayo Clinic Cancer Center Chandrakanth Are, MD¶ Fred& Pamela Buffett Cancer Center at The Nebraska Medical Center Mark Bloomston, MD¶ The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute Daniel Brown, MD Vanderbilt-Ingram Cancer Center Daniel T. Chang, MD§ Stanford Cancer Institute Anne M. Covey, MD§ Memorial Sloan Kettering Cancer Center NCCN Lauren Gallagher, RPh, PhD Karin G. Hoffmann, RN, CCM Donna Powell, MS, CMD, RT(T) Jillian Scavone, PhD Sarika Trikha, PharmD NCCN Guidelines Panel Disclosures Renuka Iyer, MDÞ Roswell Park Cancer Institute R. Kate Kelley, MD UCSF Helen Diller Family Comprehensive Cancer Center Mokenge P. Malafa, MD¶ Moffitt Cancer Center James O. Park, MD¶ Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance Timothy Pawlik, MD, MPH, PhD¶ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins James A. Posey, MD University of Alabama at Birmingham Comprehensive Cancer Center Vaibhav Sahai, MD, MS University of Michigan ComprehensiveCancer Center Courtney Scaife, MD¶ Huntsman Cancer Institute at the University of Utah Tracey Schefter, MD§ University of Colorado Cancer Center Jason K. Sicklick, MD¶ UC San Diego Moores Cancer Center

NCCN Guidelines Index Hepatobiliary Cancers Table of Contents Discussion

Elin R. Sigurdson, MD, PhD¶ Fox Chase Cancer Center Stacey Stein, MD, PhD Yale Cancer Center/Smilow Cancer Hospital G. Gary Tian, MD, PhD St. Jude Children’s Research Hospital/ The University of Tennessee Health Science Center Jean-Nicolas Vauthey, MD¶ The University of Texas MD Anderson Cancer Center Alan P. Venook, MD UCSF Helen Diller Family Comprehensive Cancer Center Rebekah White, MD¶ Duke Cancer Institute Yun Yen, MD, PhD City of Hope Comprehensive Cancer Center Andrew X. Zhu, MD, PhD Massachusetts General Hospital Cancer Center

Continue

Medical oncology§ Radiotherapy/Radiation oncology/Interventional radiology¶ Surgery/Surgical oncologyÞ Internal medicine Hemat

ology/Hematology oncology *Writing committee member

Version 2.2015, 02/06/15© National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.

http://www.77cn.com.cn

2015年3月1日,NCCN发布了肝胆肿瘤临床实践指南第1版;“新版指南”对于肝细胞癌有较多更新,主要在筛查和治疗方面进行了更详细的补充和完善。2015年6月2日,NCCN 肝胆肿瘤临床实践指南2015年第2版发布。附件为全英文原版资料,共114页,1.5M,本文件系国内首发。

Printed by Maria Chen on 2/10/2015 1:25:04 AM. For personal use only. Not approved for distribution. Copyright© 2015 National Comprehensive Cancer Network, Inc., All Rights Reserved.

NCCN Guidelines Version 2.2015 Table of Contents Hepatobiliary CancersNCCN Hepatobiliary Cancers Panel Members Summary of the Guidelines Updates Hepatocellular Carcinoma (HCC) HCC Screening (HCC-1) Diagnosis of HCC (HCC-2) HCC Confirmed, (HCC-4) Potentially Resectable or Transplantable, Operable (HCC-5) Unresectable (HCC-6) Inoperable, Local Disease, Metastatic Disease, Extensive Liver Tumor Burden (HCC-7) Child-Pugh Score (HCC-A) Principles of Surgery (HCC-B) Principles of Locoregional Therapy (HCC-C) Gallbladder Cancer Incidental Finding at Surgery (GALL-1) Incidental Finding on Pathologic Review (GALL-2) Mass on Imaging (GALL-3) Jaundice (GALL-4) Metastatic Disease (GALL-4) Post-Resection (GALL-5) Principles of Surgery (GALL-A) Intrahepatic Cholangiocarcinoma Presentation, Workup, Primary Treatment (INTRA-1) Adjuvant Treatment, Surveillance (INTRA-2) Principles of Surgery (INTRA-A) Extrahepatic Cholangiocarcinoma Presentation, Workup, Primary Treatment (EXTRA-1) Adjuvant Treatment, Surveillance (EXTRA-2) Principles of Surgery (EXTRA-A) Staging (ST-1)

NCCN Guidelines Index Hepatobiliary Cancers Table of Contents Discussion

Clinical Trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is espec …… 此处隐藏：44710字，全部文档内容请下载后查看。喜欢就下载吧 ……